14/12/2025
Danish drugmaker Novo Nordisk on Friday launched its Type 2 diabetes injection, Ozempic, which has also gained global attention for its weight-loss benefits. Ozempic (injectable semaglutide) is a once-weekly treatment indicated as an add-on to diet and exercise for adults with uncontrolled Type 2 diabetes mellitus (T2DM).
Ozempic is now available in India as 0.25 mg, 0.5 mg and 1 mg in 'FlexTouch Pen' - an easy-to-use, once-weekly pen device, at a starting cost of Rs 2,200 per week. Each pen has four once-weekly doses. A patient prescribed Ozempic injection would start with a 0.25 mg dose for four weeks at a total cost of Rs 8,800.
Afterwards, as per diagnosis by the doctor, the patient moves to either the next phase, 'step' of 0.5 mg dose for at least four weeks costing Rs 10,170 or to the 'stay' stage of 1 mg dose per week with the monthly cost pegged at Rs 11,175, it said.
Citing World Health Organisation 2023-24 estimates, the company said India has 101 million (roughly 11.4% of its population) people living with diabetes, making it the second largest diabetes-affected population in the world after China. The country also has 136 million individuals with prediabetes and 254 million people living with generalised obesity, signalling an accelerating health challenge
Source: NDTV Profit